Jeffrey S. Weber

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant (2006)

Koh, Yi T, Higgins, Sean A, Weber, Jeffrey S, Kast, W Martin

Abstract Incomplete Freund's adjuvant (IFA) serves as a carrier for water-in-oil emulsion (W/O) vaccines. The stability of such emulsions greatly affects vaccine safety and efficacy since continued...

Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray (2005)

Daniel S. Chen, Yoav Soen, Tor B. Stuge, Peter P. Lee, Jeffrey S. Weber, Patrick O. Brown, ...

Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.

Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray (2005)

Daniel S. Chen, Yoav Soen, Tor B. Stuge, Peter P. Lee, Jeffrey S. Weber, Patrick O. Brown, ...

Background In contrast to many animal model studies, immunotherapeutic trials in humans suffering from cancer invariably result in a broad range of outcomes, from long-lasting remissions to no...

Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)

Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...

State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general.

Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)

Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...

Background Melanoma patients vaccinated with tumor-associated antigens frequently develop measurable peptide-specific CD8+ T cell responses; however, such responses often do not confer clinical...

Diversity and Recognition Efficiency of T Cell Responses to Cancer

Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...

State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general

Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray

Chen, Daniel S, Soen, Yoav, Stuge, Tor B, Lee, Peter P, Weber, Jeffrey S, Brown, Patrick O, ...

Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant

Koh, Yi T, Higgins, Sean A, Weber, Jeffrey S, Kast, W Martin

Incomplete Freund's adjuvant (IFA) serves as a carrier for water-in-oil emulsion (W/O) vaccines. The stability of such emulsions greatly affects vaccine safety and efficacy since continued presence...

Diversity and Recognition Efficiency of T Cell Responses to Cancer

Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...

State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general

Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray

Chen, Daniel S, Soen, Yoav, Stuge, Tor B, Lee, Peter P, Weber, Jeffrey S, Brown, Patrick O, ...

Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant

Koh, Yi T, Higgins, Sean A, Weber, Jeffrey S, Kast, W Martin

Incomplete Freund's adjuvant (IFA) serves as a carrier for water-in-oil emulsion (W/O) vaccines. The stability of such emulsions greatly affects vaccine safety and efficacy since continued presence...